story of the week
SGLT2 Inhibitors in Hospitalised Patients With COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sodium-glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials
Lancet Diabetes Endocrinol 2024 Sep 05;[EPub Ahead of Print], C Vale, PJ Godolphin, D Fisher, PW Horby, MN Kosiborod, JS Hochman, K Webster, JPT Higgins, AD Althouse, O Berwanger, RHM Furtado, SB Gasparyan, R Haynes, GG Koch, M Landray, E Leifer, J Marshall, S Murthy, MD Neal, N Staplin, J Diaz, JAC Sterne, M Shankar-HariFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.